Journal of Medical Economics
Volume 24, 2021 - Issue 1
Open access
1,728
Views
2
CrossRef citations to date
0
Altmetric
Cardiovascular
Healthcare costs before and after stroke in patients with non-valvular atrial fibrillation who initiated treatment with rivaroxaban or warfarin
Dejan Milentijevica Janssen Scientific Affairs, LLC, Titusville, NJ, USACorrespondence[email protected]
https://orcid.org/0000-0003-2159-0049
Jennifer H. Lina Janssen Scientific Affairs, LLC, Titusville, NJ, USA
, Yen-Wen Chena Janssen Scientific Affairs, LLC, Titusville, NJ, USA
, Emily Koganb Janssen Research & Development, LLC, Raritan, NJ, USA
https://orcid.org/0000-0003-1364-6743
Shubham Shrivastavac Mu Sigma Business Solutions Pvt. Ltd, Bengaluru, India
, Erik Sjoelandb Janssen Research & Development, LLC, Raritan, NJ, USA
& Mark Albertsd Hartford HealthCare, Hartford, CT, USA
https://orcid.org/0000-0001-5488-6810
Pages 212-217
|
Received 20 Aug 2020, Accepted 05 Jan 2021, Published online: 13 Feb 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.